Dexcel Pharma USA Appoints Daniel Connell as Chief Financial Officer
PRIVATEAug 01, 2026
Position
Chief Financial Officer
Company
Dexcel Pharma USA
Daniel Connell
New JerseyManufacturingBiotechnologyPharmaceutical
Description
Dexcel Pharma USA has strengthened its executive leadership team by appointing Daniel Connell as Senior Vice President & Chief Financial Officer. Connell will lead the company's financial strategy and support its continued growth in the specialty pharmaceutical market.
Who to call at Dexcel Pharma USA, and when
A new leader at Dexcel Pharma USA brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Dexcel Pharma USA raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Dexcel Pharma USA, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Dexcel Pharma USA
Location
New Jersey, United States
About
Dexcel Pharma USA is the U.S. subsidiary of Dexcel Pharma, the largest private pharmaceutical company in Israel. It commercializes an extensive portfolio of branded and generic drugs. The company focuses on developing and manufacturing high-quality products. It also strives to maintain long-term partnerships across the value chain.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Dexcel Pharma USA changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
New JerseyManufacturingBiotechnologyPharmaceutical